Literature DB >> 32583138

Machine learning-based analysis of CT radiomics model for prediction of colorectal metachronous liver metastases.

Marjaneh Taghavi1,2, Stefano Trebeschi1,2, Rita Simões3, David B Meek1, Rianne C J Beckers1,2, Doenja M J Lambregts1, Cornelis Verhoef4, Janneke B Houwers2,5, Uulke A van der Heide3, Regina G H Beets-Tan1,2, Monique Maas6.   

Abstract

PURPOSE: Early identification of patients at risk of developing colorectal liver metastases can help personalizing treatment and improve oncological outcome. The aim of this study was to investigate in patients with colorectal cancer (CRC) whether a machine learning-based radiomics model can predict the occurrence of metachronous metastases.
METHODS: In this multicentre study, the primary staging portal venous phase CT of 91 CRC patients were retrospectively analysed. Two groups were assessed: patients without liver metastases at primary staging, or during follow-up of ≥ 24 months (n = 67) and patients without liver metastases at primary staging but developed metachronous liver metastases < 24 months after primary staging (n = 24). After liver parenchyma segmentation, 1767 radiomics features were extracted for each patient. Three predictive models were constructed based on (1) radiomics features, (2) clinical features and (3) a combination of clinical and radiomics features. Stability of features across hospitals was assessed by the Kruskal-Wallis test and inter-correlated features were removed if their correlation coefficient was higher than 0.9. Bayesian-optimized random forest with wrapper feature selection was used for prediction models.
RESULTS: The three predictive models that included radiomics features, clinical features and a combination of radiomics with clinical features resulted in an AUC in the validation cohort of 86% (95%CI 85-87%), 71% (95%CI 69-72%) and 86% (95% CI 85-87%), respectively.
CONCLUSION: A machine learning-based radiomics analysis of routine clinical CT imaging at primary staging can provide valuable biomarkers to identify patients at high risk for developing colorectal liver metastases.

Entities:  

Keywords:  Colorectal cancer; Liver neoplasms; Machine learning; Neoplasm metastasis; Tomography; X-ray computed

Mesh:

Year:  2021        PMID: 32583138     DOI: 10.1007/s00261-020-02624-1

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  3 in total

1.  Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative MRI: a radiomics study.

Authors:  T C H Hui; T K Chuah; H M Low; C H Tan
Journal:  Clin Radiol       Date:  2018-09-10       Impact factor: 2.350

2.  Establishment of a new non-invasive imaging prediction model for liver metastasis in colon cancer.

Authors:  Yu Li; Aydin Eresen; Junjie Shangguan; Jia Yang; Yun Lu; Dong Chen; Jian Wang; Yury Velichko; Vahid Yaghmai; Zhuoli Zhang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

3.  Factors influencing incidence and extension of metachronous liver metastases of colorectal adenocarcinoma. A multivariate analysis.

Authors:  G B Secco; R Fardelli; D Gianquinto; P Bonfante; E Baldi; E Campora
Journal:  Hepatogastroenterology       Date:  1997 Jul-Aug
  3 in total
  10 in total

1.  Developing a new radiomics-based CT image marker to detect lymph node metastasis among cervical cancer patients.

Authors:  Xuxin Chen; Wei Liu; Theresa C Thai; Tara Castellano; Camille C Gunderson; Kathleen Moore; Robert S Mannel; Hong Liu; Bin Zheng; Yuchen Qiu
Journal:  Comput Methods Programs Biomed       Date:  2020-09-16       Impact factor: 5.428

2.  Early Diagnosis of Liver Metastases from Colorectal Cancer through CT Radiomics and Formal Methods: A Pilot Study.

Authors:  Aldo Rocca; Maria Chiara Brunese; Antonella Santone; Pasquale Avella; Paolo Bianco; Andrea Scacchi; Mariano Scaglione; Fabio Bellifemine; Roberta Danzi; Giulia Varriano; Gianfranco Vallone; Fulvio Calise; Luca Brunese
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

Review 3.  Artificial intelligence in the diagnosis and management of colorectal cancer liver metastases.

Authors:  Gianluca Rompianesi; Francesca Pegoraro; Carlo Dl Ceresa; Roberto Montalti; Roberto Ivan Troisi
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

4.  Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis.

Authors:  Yue Li; Jing Gong; Xigang Shen; Menglei Li; Huan Zhang; Feng Feng; Tong Tong
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

5.  Machine learning-based Radiomics analysis for differentiation degree and lymphatic node metastasis of extrahepatic cholangiocarcinoma.

Authors:  Yong Tang; Chun Mei Yang; Song Su; Wei Jia Wang; Li Ping Fan; Jian Shu
Journal:  BMC Cancer       Date:  2021-11-24       Impact factor: 4.430

Review 6.  The Hepatic Pre-Metastatic Niche.

Authors:  Benjamin Ormseth; Amblessed Onuma; Hongji Zhang; Allan Tsung
Journal:  Cancers (Basel)       Date:  2022-07-31       Impact factor: 6.575

7.  Whole-liver enhanced CT radiomics analysis to predict metachronous liver metastases after rectal cancer surgery.

Authors:  Meng Liang; Xiaohong Ma; Hongmei Zhang; Xinming Zhao; Leyao Wang; Dengfeng Li; Sicong Wang
Journal:  Cancer Imaging       Date:  2022-09-11       Impact factor: 5.605

Review 8.  The Role of Biomarkers in the Management of Colorectal Liver Metastases.

Authors:  Daniel Brock Hewitt; Zachary J Brown; Timothy M Pawlik
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

9.  Contrast Administration Impacts CT-Based Radiomics of Colorectal Liver Metastases and Non-Tumoral Liver Parenchyma Revealing the "Radiological" Tumour Microenvironment.

Authors:  Francesco Fiz; Guido Costa; Nicolò Gennaro; Ludovico la Bella; Alexandra Boichuk; Martina Sollini; Letterio S Politi; Luca Balzarini; Guido Torzilli; Arturo Chiti; Luca Viganò
Journal:  Diagnostics (Basel)       Date:  2021-06-25

Review 10.  Applications of Artificial Intelligence in Screening, Diagnosis, Treatment, and Prognosis of Colorectal Cancer.

Authors:  Hang Qiu; Shuhan Ding; Jianbo Liu; Liya Wang; Xiaodong Wang
Journal:  Curr Oncol       Date:  2022-03-07       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.